Loading...
XSHG
603739
Market cap534mUSD
Dec 05, Last price  
14.93CNY
1D
1.43%
1Q
2.26%
IPO
-37.48%
Name

Qingdao Vland Biotech Co Ltd

Chart & Performance

D1W1MN
XSHG:603739 chart
P/E
60.31
P/S
2.86
EPS
0.25
Div Yield, %
0.67%
Shrs. gr., 5y
2.96%
Rev. gr., 5y
9.30%
Revenues
1.32b
+10.16%
728,223,334751,723,670781,229,944799,439,774813,970,528846,777,962960,249,3541,150,823,5651,163,162,7811,198,902,1031,320,761,061
Net income
63m
-22.39%
53,234,92070,265,77582,550,44285,625,17683,384,93877,752,946108,976,210132,573,19669,842,00780,706,91162,637,482
CFO
195m
+27.22%
58,547,60074,268,465154,487,354121,900,84485,751,37965,327,125172,997,19089,513,69995,306,379153,592,321195,407,571
Dividend
May 30, 20240.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Qingdao Vland Biotech INC. engages in the research and development of enzymes, probiotics, and animal vaccines and health products. It offers animal feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated poultry, and swine vaccines, as well as antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, paper making, household cleaning and detergents, food, biofuel, environmental protection, and other industries. The company was incorporated in 2005 and is headquartered in Qingdao, China. Qingdao Vland Biotech INC. operates as a subsidiary of Qingdao Kangdien Industrial Co., Ltd.
IPO date
Jan 16, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT